Form4.ai tracks every SEC insider trade in real time. See every PHIO insider filing with a free account — no card.
See every PHIO insider filing — free account, no card.
Free accountPhio Pharmaceuticals Corp. (PHIO) has 11 SEC Form 4 insider filings on record in the last 90 days. That includes 6 insider purchases totalling $59K. Most recent filing: Sept. 30, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 30, 2026 SEC filing | Plott Ronald Todd Director | Bought | $10,350 | -11.4% 30D |
| Sep 29, 2026 SEC filing | Bitterman Robert J Chairman, Pres. & CEO | Grant / award | — | — |
| Sep 29, 2026 SEC filing | Carson Lisa Cabott Chief Financial Officer | Grant / award | — | — |
Create a free account to see all 11 PHIO filings from the last 90 days. No card needed.
Create free accountWant PHIO insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.